Federica del Monte to Genetic Therapy
This is a "connection" page, showing publications Federica del Monte has written about Genetic Therapy.
Connection Strength
1.124
-
Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation. 2008 Aug 05; 118(6):614-24.
Score: 0.261
-
Targeted gene transfer in heart failure: implications for novel gene identification. Curr Opin Mol Ther. 2004 Aug; 6(4):381-94.
Score: 0.198
-
Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2010 Dec; 49(6):993-1002.
Score: 0.076
-
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am J Physiol Heart Circ Physiol. 2009 Feb; 296(2):H310-7.
Score: 0.067
-
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther. 2007 Jul; 14(13):989-97.
Score: 0.059
-
Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications. Expert Rev Cardiovasc Ther. 2005 Jan; 3(1):85-97.
Score: 0.051
-
In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation. 2004 Nov 30; 110(22):3435-43.
Score: 0.051
-
Gene transfer in cardiac myocytes. Surg Clin North Am. 2004 Feb; 84(1):141-59, ix-x.
Score: 0.048
-
Gene therapy for the treatment of heart failure--calcium signaling. Semin Thorac Cardiovasc Surg. 2003 Jul; 15(3):268-76.
Score: 0.046
-
Modulating signaling pathways in hypertrophy and heart failure by gene transfer. J Card Fail. 2002 Dec; 8(6 Suppl):S389-400.
Score: 0.044
-
Targeting phospholamban by gene transfer in human heart failure. Circulation. 2002 Feb 26; 105(8):904-7.
Score: 0.042
-
Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation. 2001 Sep 18; 104(12):1424-9.
Score: 0.041
-
Prospects for gene therapy for heart failure. Circ Res. 2000 Mar 31; 86(6):616-21.
Score: 0.037
-
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol. 2007 Apr; 42(4):852-61.
Score: 0.015
-
Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. Mol Ther. 2006 May; 13(5):987-96.
Score: 0.014
-
SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr. 2005 Dec; 37(6):375-80.
Score: 0.014
-
Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res. 2005 Sep 02; 97(5):488-95.
Score: 0.013
-
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol. 2005 Jun; 288(6):H2995-3000.
Score: 0.013
-
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res. 2005 Apr 15; 96(7):756-66.
Score: 0.013
-
Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging. 2004 Apr; 3(2):69-75.
Score: 0.012
-
Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging. 2002 Oct; 1(4):365-77.
Score: 0.011